ANTENGENE CORPORATIO

6996
End-of-day quote. End-of-day quote  - 07/23
16.9HKD 0.00%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The Company mainly conducts its business in Asia-Pacific.
Managers
Name Title
Jian Ming Mei Chairman & Chief Executive Officer
Donald Andrew Lung Chief Financial Officer & Executive Director
Bo Shan Chief Scientific Officer
Kevin Lynch Executive Director & Chief Medical Officer
Yiteng Liu Chief Operating Officer
Mark J. Alles Independent Non-Executive Director
Jing Qian Independent Non-Executive Director
Sheng Tang Independent Non-Executive Director
John F. Chin Executive Director & Chief Business Officer
Yan Ling Cao Non-Executive Director
Shareholders
Name Equities %
Horsham Angel Investment Ltd. 175,927,994 26.2%
Boyu Capital Advisory Co. Ltd. 73,789,650 11.0%
Fountainvest Partners (Asia) Ltd. 57,010,396 8.49%
The Core Trust Co., Ltd. 45,702,232 6.81%
Qiming Venture Partners Ltd. 40,170,442 5.99%
Fidelity Management & Research (Hong Kong) Ltd. 34,854,834 5.19%
Yiteng Liu 13,695,500 2.04%
Fidelity Management & Research Co. LLC 10,919,303 1.63%
GIC Pte Ltd. (Investment Management) 8,573,500 1.28%
Sequoia Capital China Advisors (Hong Kong) Ltd. 6,430,000 0.96%
Sector Bio Therapeutic Drugs
1st jan.Capi. (M$)
ANTENGENE CORPORATION LIMITED-1.40%1 686
GILEAD SCIENCES, INC.18.47%85 134
WUXI APPTEC CO., LTD.37.17%71 226
REGENERON PHARMACEUTICALS21.37%57 013
BIONTECH SE245.88%55 555
VERTEX PHARMACEUTICALS-15.16%50 308
BEIGENE, LTD.24.51%33 627
GENMAB A/S13.64%27 394
ARGENX SE10.70%16 311
HUALAN BIOLOGICAL ENGINEERING INC.-9.75%10 439
NEUROCRINE BIOSCIENCES, INC.2.79%9 482
ARROWHEAD PHARMACEUTICALS, INC.-10.90%9 401
DENALI THERAPEUTICS INC.-22.95%9 051
MIRATI THERAPEUTICS, INC.-27.46%8 451
FATE THERAPEUTICS, INC.-5.21%7 951
REMEGEN CO., LTD.0.58%7 820
ACCELERON PHARMA INC.-4.01%7 722
ASCENDIS PHARMA A/S-30.65%7 555
EXELIXIS, INC.-16.64%7 340
GW PHARMACEUTICALS PLC89.72%6 907
AKESO, INC.39.34%6 690